Logo PTC Therapeutics, Inc.

PTC Therapeutics, Inc. (PTCT) stock: analyst price target and their real reliability

Live quote · data updated Aug 28, 2026
PTC Therapeutics, Inc. · Health Care · ref. ETF XLV · 92 calls · price $71.81
💬JPI AI AssistantTry it →
What the company does: PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to children and adults living with rare disorders in the United States and internationally.

📈 PTC Therapeutics, Inc. (PTCT) stock price

$71.81+44.2% over range
Aug 28, 25low $49.33 · high $89.55Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
86% recommend buying · 7 analysts
📊 JPI status : PTC Therapeutics, Inc. has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →

🎯 PTCT price target & analyst consensusprice $71.81

The price target · all analysts combined (7 targets)
Highest target · 1 firm of 7$130+81.0%
Median target · of 7 targets$104+44.8%
Lowest target · 2 firms of 7$85+18.4%
Current price$71.81
Where these 7 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price 7100% $85 ↔ $130
⭐ What the most reliable analysts say

No reliable analyst is bullish on this stock right now. A “reliable” analyst is a firm that, on this sector, hits more than 55% of its targets and beats its sector. None of them sees upside here — which is exactly why this stock is in no JPI selection.

The consensus · 7 ratings (last 6 months)
Strong Buy00%
Buy686%
Hold114%
Sell00%
Strong Sell00%
Go deeper on the analysts
All analysts (the consensus)  ·  vs  ·  the best (those who've been right)
💬 A question about PTC Therapeutics, Inc.? The JPI assistant answers using our backtest data.

🔎 Detailed analyses

✅ Historical analyst reliability on PTCT

Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.

Firm % right i Gain vs sector i Calls i
Baird  100% +69.4% 6
Wells Fargo  100% +59.7% 5
UBS  100% +46.9% 3
Wedbush  100% +30.1% 2
RBC Capital  86% +37.3% 7
Cantor Fitzgerald  76% +34.0% 25
Jefferies  75% +36.2% 4
Morgan Stanley  75% +26.1% 4
JP Morgan  71% +11.8% 14
Truist Securities  67% +19.1% 6
See the other 9 firms
Raymond James  0% -29.9% 9
Goldman Sachs  33% -14.1% 6
Barclays  33% +1.7% 3
SunTrust Robinson Humphrey 33% +5.6% 3
Citigroup  36% -21.5% 14
B of A Securities  44% -3.6% 16
Deutsche Bank  50% -44.7% 2
Cowen & Co. 67% +15.6% 3
Credit Suisse 67% +17.6% 9

📊 What $1,000 invested in PTC Therapeutics, Inc. would be worth › open the full page

In short — $1,000 invested in PTC Therapeutics, Inc. 10 years ago would be worth $2,409 today, i.e. +9%/yr on average. Best year: 2018 (+106%), worst: 2016 (-66%). Price performance, excluding dividends.

If I'd invested $1,000 in PTC Therapeutics, Inc.

InvestmentWorth todayGain
1 years ago$1,729+73%
3 years ago$2,045+105%
5 years ago$1,279+28%
→ See PTC Therapeutics, Inc.'s full return history + gain calculator

Return by year (PTC Therapeutics, Inc.)

YearReturn$1,000 invested at year start
2026 (YTD)+3%$1,028 (+3%)
2025+68%$1,729 (+73%)
2024+64%$2,832 (+183%)
→ See PTC Therapeutics, Inc.'s full return history + gain calculator
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

📰 Recent news on PTC Therapeutics, Inc.

Loading news…

📋 All analyst calls on PTCT

Barclays 
Aug 14, 26
▲ Overweight · 🎯$122
Price at call : $72.88 — upside +67%
Today : $71.81 — upside +70%
🎯 on PTCT : no call matured yet · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : Aug 14, 27
Wells Fargo 
Aug 13, 26
▲ Overweight · 🎯$109
Price at call : $71.7 — upside +52%
Today : $71.81 — upside +52%
🎯 on PTCT : 100% (4 calls matureds) · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : Aug 13, 27
Morgan Stanley 
Jul 31, 26
▲ Overweight · 🎯$104
Price at call : $68.11 — upside +53%
Today : $71.81 — upside +45%
🎯 on PTCT : 100% (2 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)
in progress (365j)
matures : Jul 31, 27
Wells Fargo 
Jul 31, 26
▲ Overweight · 🎯$106
Price at call : $68.11 — upside +56%
Today : $71.81 — upside +48%
🎯 on PTCT : 100% (4 calls matureds) · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : Jul 31, 27
Wells Fargo 
Jul 20, 26
▲ Overweight · 🎯$93
Price at call : $78.01 — upside +19%
Today : $71.81 — upside +30%
🎯 on PTCT : 100% (4 calls matureds) · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : Jul 20, 27
▲ Overweight · 🎯$130
Price at call : $78.52 — upside +66%
Today : $71.81 — upside +81%
🎯 on PTCT : 100% (12 calls matureds) · 📊 on Health : 50.6% · +13.8% (166 calls)
in progress (365j)
matures : Jul 16, 27
RBC Capital 
Jul 7, 26
■ Sector Perform neutral · not a buy · 🎯$85
Price at call : $88.57 — gap to target -4%
Today : $71.81 — gap to target +18%
🎯 on PTCT : 100% (3 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
in progress (365j)
matures : Jul 7, 27
Jefferies 
May 27, 26
▲ Buy · 🎯$85
Price at call : $71.05 — upside +20%
Today : $71.81 — upside +18%
🎯 on PTCT : no call matured yet · 📊 on Health : 50% · +9.9% (136 calls)
in progress (365j)
matures : May 27, 27
See the other 84 calls, newest to oldest
TD Cowen 
May 8, 26
▲ Buy · 🎯$90
Price at call : $76.85 — upside +17%
Today : $71.81 — upside +25%
🎯 on PTCT : no call matured yet · 📊 on Health : 55.3% · -0.8% (38 calls)
in progress (365j)
matures : May 8, 27
RBC Capital 
May 8, 26
■ Sector Perform neutral · not a buy · 🎯$82
Price at call : $76.85 — gap to target +7%
Today : $71.81 — gap to target +14%
🎯 on PTCT : 100% (3 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
in progress (365j)
matures : May 8, 27
Wells Fargo 
May 8, 26
▲ Overweight · 🎯$95
Price at call : $76.85 — upside +24%
Today : $71.81 — upside +32%
🎯 on PTCT : 100% (4 calls matureds) · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : May 8, 27
Jefferies 
Mar 30, 26
■ Hold neutral · not a buy · 🎯$76
Price at call : $68.13 — gap to target +12%
Today : $71.81 — gap to target +6%
🎯 on PTCT : no call matured yet · 📊 on Health : 50% · +9.9% (136 calls)
in progress (365j)
matures : Mar 30, 27
Morgan Stanley 
Feb 23, 26
▲ Overweight · 🎯$92
Price at call : $68.98 — upside +33%
Today : $71.81 — upside +28%
🎯 on PTCT : 100% (2 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)
in progress (365j)
matures : Feb 23, 27
Wells Fargo 
Feb 20, 26
▲ Overweight · 🎯$86
Price at call : $70.5 — upside +22%
Today : $71.81 — upside +20%
🎯 on PTCT : 100% (4 calls matureds) · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : Feb 20, 27
RBC Capital 
Feb 20, 26
■ Sector Perform neutral · not a buy · 🎯$82
Price at call : $70.5 — gap to target +16%
Today : $71.81 — gap to target +14%
🎯 on PTCT : 100% (3 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
in progress (365j)
matures : Feb 20, 27
▲ Buy · 🎯$93
Price at call : $70.66 — upside +32%
Today : $71.81 — upside +30%
🎯 on PTCT : 58% (12 calls matureds) · 📊 on Health : 51.3% · +3.0% (152 calls)
in progress (365j)
matures : Feb 20, 27
Barclays 
Jan 28, 26
▲ Overweight · 🎯$119
Price at call : $76.43 — upside +56%
Today : $71.81 — upside +66%
🎯 on PTCT : no call matured yet · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : Jan 28, 27
RBC Capital 
Dec 1, 25
■ Sector Perform neutral · not a buy · 🎯$91
Price at call : $79.2 — gap to target +15%
Today : $71.81 — gap to target +27%
🎯 on PTCT : 100% (3 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
in progress (365j)
matures : Dec 1, 26
Barclays 
Nov 6, 25
■ Equal-Weight neutral · not a buy · 🎯$68
Price at call : $71.78 — gap to target -5%
Today : $71.81 — gap to target -5%
🎯 on PTCT : no call matured yet · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : Nov 6, 26
Citigroup 
Nov 5, 25
■ Neutral neutral · not a buy · 🎯$75
Price at call : $72.59 — gap to target +3%
Today : $71.81 — gap to target +4%
🎯 on PTCT : 25% (12 calls matureds) · 📊 on Health : 43.8% · -5.4% (105 calls)
in progress (365j)
matures : Nov 5, 26
TD Cowen 
Nov 5, 25
■ Hold neutral · not a buy · 🎯$63
Price at call : $72.59 — gap to target -13%
Today : $71.81 — gap to target -12%
🎯 on PTCT : no call matured yet · 📊 on Health : 55.3% · -0.8% (38 calls)
in progress (365j)
matures : Nov 5, 26
RBC Capital 
Nov 5, 25
▲ Outperform · 🎯$82
Price at call : $72.59 — upside +13%
Today : $71.81 — upside +14%
🎯 on PTCT : 100% (3 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
in progress (365j)
matures : Nov 5, 26
Goldman Sachs 
Nov 5, 25
▼ Sell · 🎯$50
Price at call : $72.59 — upside -31%
Today : $71.81 — upside -30%
🎯 on PTCT : no call matured yet · 📊 on Health : 51% · +5.1% (102 calls)
in progress (365j)
matures : Nov 5, 26
Wells Fargo 
Nov 5, 25
▲ Overweight · 🎯$93
Price at call : $72.59 — upside +28%
Today : $71.81 — upside +30%
🎯 on PTCT : 100% (4 calls matureds) · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : Nov 5, 26
Jefferies 
Oct 28, 25
▲ Buy · 🎯$77
Price at call : $67.35 — upside +14%
Today : $71.81 — upside +7%
🎯 on PTCT : no call matured yet · 📊 on Health : 50% · +9.9% (136 calls)
in progress (365j)
matures : Oct 28, 26
▲ Overweight · 🎯$118
Price at call : $58.01 — upside +103%
Today : $71.81 — upside +64%
🎯 on PTCT : 100% (12 calls matureds) · 📊 on Health : 50.6% · +13.8% (166 calls)
in progress (365j)
matures : Sep 3, 26
Wells Fargo 
Aug 20, 25
▲ Overweight · 🎯$73
Price at call : $48.92 — upside +49%
Today : $71.81 — upside +2%
Expected +49% · Actual +43% · Reason (≥ +15%) : ✓ Yes
🎯 on PTCT : 100% (4 calls matureds) · 📊 on Health : 37.5% · +1.0% (104 calls)
+42.7%
stock +43% · XLV +27%
matured Aug 20, 26
Morgan Stanley 
Aug 20, 25
▲ Overweight · 🎯$71
Price at call : $48.92 — upside +45%
Today : $71.81 — upside -1%
Expected +45% · Actual +43% · Reason (≥ +15%) : ✓ Yes
🎯 on PTCT : 100% (2 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)
+42.7%
stock +43% · XLV +27%
matured Aug 20, 26
▲ Buy · 🎯$76
Price at call : $48.85 — upside +56%
Today : $71.81 — upside +6%
Expected +56% · Actual +44% · Reason (≥ +15%) : ✓ Yes
🎯 on PTCT : 58% (12 calls matureds) · 📊 on Health : 51.3% · +3.0% (152 calls)
+44.4%
stock +44% · XLV +25%
matured Aug 20, 26
▲ Overweight · 🎯$76
Price at call : $43.3 — upside +76%
Today : $71.81 — upside +6%
Expected +76% · Actual +72% · Reason (≥ +15%) : ✓ Yes
🎯 on PTCT : 100% (2 calls matureds) · 📊 on Health : 55.5% · +4.6% (182 calls)
+72.4%
stock +72% · XLV +29%
matured Aug 8, 26
RBC Capital 
Aug 8, 25
▲ Outperform · 🎯$63
Price at call : $43.3 — upside +45%
Today : $71.81 — upside -12%
Expected +45% · Actual +72% · Reason (≥ +15%) : ✓ Yes
🎯 on PTCT : 100% (3 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
+72.4%
stock +72% · XLV +29%
matured Aug 8, 26
Wells Fargo 
Aug 8, 25
▲ Overweight · 🎯$79
Price at call : $43.3 — upside +82%
Today : $71.81 — upside +10%
Expected +82% · Actual +72% · Reason (≥ +15%) : ✓ Yes
🎯 on PTCT : 100% (4 calls matureds) · 📊 on Health : 37.5% · +1.0% (104 calls)
+72.4%
stock +72% · XLV +29%
matured Aug 8, 26
▲ Buy · 🎯$86
Price at call : $50.94 — upside +69%
Today : $71.81 — upside +20%
Expected +69% · Actual +48% · Reason (≥ +15%) : ✓ Yes
🎯 on PTCT : 100% (2 calls matureds) · 📊 on Health : 37.6% · -0.8% (165 calls)
+48.3%
stock +48% · XLV +22%
matured Jul 29, 26
▲ Buy · 🎯$84
Price at call : $50.94 — upside +65%
Today : $71.81 — upside +17%
Expected +65% · Actual +48% · Reason (≥ +15%) : ✓ Yes
🎯 on PTCT : 58% (12 calls matureds) · 📊 on Health : 51.3% · +3.0% (152 calls)
+48.3%
stock +48% · XLV +22%
matured Jul 29, 26
Barclays 
Jul 29, 25
■ Equal-Weight neutral · not a buy · 🎯$46
Price at call : $50.94 — gap to target -10%
Today : $71.81 — gap to target -36%
🎯 on PTCT : no call matured yet · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : Jul 29, 26
Wells Fargo 
Jul 29, 25
▲ Overweight · 🎯$78
Price at call : $50.94 — upside +53%
Today : $71.81 — upside +9%
Expected +53% · Actual +48% · Reason (≥ +15%) : ✓ Yes
🎯 on PTCT : 100% (4 calls matureds) · 📊 on Health : 37.5% · +1.0% (104 calls)
+48.3%
stock +48% · XLV +22%
matured Jul 29, 26
▲ Overweight · 🎯$120
Price at call : $50.94 — upside +136%
Today : $71.81 — upside +67%
Expected +136% · Actual +48% · Reason (≥ +15%) : ✓ Yes
🎯 on PTCT : 100% (12 calls matureds) · 📊 on Health : 50.6% · +13.8% (166 calls)
+48.3%
stock +48% · XLV +22%
matured Jul 29, 26
UBS 
Jul 29, 25
▲ Buy · 🎯$80
Price at call : $50.94 — upside +57%
Today : $71.81 — upside +11%
Expected +57% · Actual +48% · Reason (≥ +15%) : ✓ Yes
🎯 on PTCT : 100% (1 call matured) · 📊 on Health : 50% · +2.7% (74 calls)
+48.3%
stock +48% · XLV +22%
matured Jul 29, 26
Citigroup 
Jul 28, 25
■ Neutral neutral · not a buy · 🎯$50
Price at call : $49.29 — gap to target +1%
Today : $71.81 — gap to target -30%
🎯 on PTCT : 25% (12 calls matureds) · 📊 on Health : 43.8% · -5.4% (105 calls)
in progress (365j)
matures : Jul 28, 26
▲ Buy · 🎯$80
Price at call : $50.43 — upside +59%
Today : $71.81 — upside +11%
Expected +59% · Actual +57% · Reason (≥ +15%) : ✓ Yes
🎯 on PTCT : 100% (2 calls matureds) · 📊 on Health : 37.6% · -0.8% (165 calls)
+56.6%
stock +57% · XLV +12%
matured Jun 17, 26
Wells Fargo 
May 27, 25
▲ Overweight · 🎯$74
Price at call : $47.86 — upside +55%
Today : $71.81 — upside +3%
Expected +55% · Actual +48% · Reason (≥ +15%) : ✓ Yes
🎯 on PTCT : 100% (4 calls matureds) · 📊 on Health : 37.5% · +1.0% (104 calls)
+47.6%
stock +48% · XLV +13%
matured May 27, 26
▲ Buy · 🎯$68
Price at call : $44.23 — upside +54%
Today : $71.81 — upside -5%
Expected +54% · Actual +74% · Reason (≥ +15%) : ✓ Yes
🎯 on PTCT : 58% (12 calls matureds) · 📊 on Health : 51.3% · +3.0% (152 calls)
+73.8%
stock +74% · XLV +8%
matured May 9, 26
Barclays 
May 8, 25
■ Equal-Weight neutral · not a buy · 🎯$42
Price at call : $44.23 — gap to target -5%
Today : $71.81 — gap to target -42%
🎯 on PTCT : no call matured yet · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : May 8, 26
Baird 
May 7, 25
▲ Outperform · 🎯$66
Price at call : $42.51 — upside +55%
Today : $71.81 — upside -8%
Expected +55% · Actual +73% · Reason (≥ +15%) : ✓ Yes
🎯 on PTCT : 100% (1 call matured) · 📊 on Health : 37.8% · -2.8% (82 calls)
+73.4%
stock +73% · XLV +7%
matured May 7, 26
RBC Capital 
May 7, 25
▲ Outperform · 🎯$58
Price at call : $42.51 — upside +36%
Today : $71.81 — upside -19%
Expected +36% · Actual +73% · Reason (≥ +15%) : ✓ Yes
🎯 on PTCT : 100% (3 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
+73.4%
stock +73% · XLV +7%
matured May 7, 26
▲ Overweight · 🎯$112
Price at call : $42.51 — upside +163%
Today : $71.81 — upside +56%
Expected +163% · Actual +73% · Reason (≥ +15%) : ✓ Yes
🎯 on PTCT : 100% (12 calls matureds) · 📊 on Health : 50.6% · +13.8% (166 calls)
+73.4%
stock +73% · XLV +7%
matured May 7, 26
JP Morgan 
May 7, 25
▲ Overweight · 🎯$67
Price at call : $40.76 — upside +64%
Today : $71.81 — upside -7%
Expected +64% · Actual +58% · Reason (≥ +15%) : ✓ Yes
🎯 on PTCT : 67% (12 calls matureds) · 📊 on Health : 49.3% · +6.9% (146 calls)
+58.2%
stock +58% · XLV +7%
matured May 7, 26
Citigroup 
May 7, 25
■ Neutral neutral · not a buy · 🎯$40
Price at call : $40.76 — gap to target -2%
Today : $71.81 — gap to target -44%
🎯 on PTCT : 25% (12 calls matureds) · 📊 on Health : 43.8% · -5.4% (105 calls)
in progress (365j)
matures : May 7, 26
RBC Capital 
Apr 22, 25
▲ Outperform · 🎯$65
Price at call : $49.95 — upside +30%
Today : $71.81 — upside -9%
Expected +30% · Actual +37% · Reason (≥ +15%) : ✓ Yes
🎯 on PTCT : 100% (3 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
+37.3%
stock +37% · XLV +8%
matured Apr 22, 26
JP Morgan 
Mar 31, 25
▲ Overweight · 🎯$75
Price at call : $46.6 — upside +61%
Today : $71.81 — upside +4%
Expected +61% · Actual +48% · Reason (≥ +15%) : ✓ Yes
🎯 on PTCT : 67% (12 calls matureds) · 📊 on Health : 49.3% · +6.9% (146 calls)
+47.5%
stock +48% · XLV +3%
matured Mar 31, 26
JP Morgan 
Mar 14, 25
▲ Overweight · 🎯$78
Price at call : $57.17 — upside +36%
Today : $71.81 — upside +9%
Expected +36% · Actual +17% · Reason (≥ +15%) : ✓ Yes
🎯 on PTCT : 67% (12 calls matureds) · 📊 on Health : 49.3% · +6.9% (146 calls)
+16.7%
stock +17% · XLV +3%
matured Mar 14, 26
JP Morgan 
Feb 28, 25
▲ Overweight · 🎯$72
Price at call : $52.87 — upside +36%
Today : $71.81 — upside +0%
Expected +36% · Actual +26% · Reason (≥ +15%) : ✓ Yes
🎯 on PTCT : 67% (12 calls matureds) · 📊 on Health : 49.3% · +6.9% (146 calls)
+25.5%
stock +26% · XLV +6%
matured Feb 28, 26
Citigroup 
Feb 12, 25
▼ Sell · 🎯$45
Price at call : $48.93 — upside -8%
Today : $71.81 — upside -37%
Expected -8% · Actual +44% · Reason (≤ −15%) : ✗ No
🎯 on PTCT : 25% (12 calls matureds) · 📊 on Health : 43.8% · -5.4% (105 calls)
-44.5%
stock +44% · XLV +7%
matured Feb 12, 26
▲ Overweight · 🎯$113
Price at call : $49.38 — upside +129%
Today : $71.81 — upside +57%
Expected +129% · Actual +50% · Reason (≥ +15%) : ✓ Yes
🎯 on PTCT : 100% (12 calls matureds) · 📊 on Health : 50.6% · +13.8% (166 calls)
+49.7%
stock +50% · XLV +6%
matured Feb 3, 26
▲ Overweight · 🎯$76
Price at call : $42.27 — upside +80%
Today : $71.81 — upside +6%
Expected +80% · Actual +79% · Reason (≥ +15%) : ✓ Yes
🎯 on PTCT : 100% (12 calls matureds) · 📊 on Health : 50.6% · +13.8% (166 calls)
+78.9%
stock +79% · XLV +12%
matured Jan 15, 26
Citigroup 
Dec 4, 24
▼ Sell · 🎯$32
Price at call : $48.4 — upside -34%
Today : $71.81 — upside -55%
Expected -34% · Actual +60% · Reason (≤ −15%) : ✗ No
🎯 on PTCT : 25% (12 calls matureds) · 📊 on Health : 43.8% · -5.4% (105 calls)
-59.6%
stock +60% · XLV +6%
matured Dec 4, 25
JP Morgan 
Nov 19, 24
▲ Overweight · 🎯$62
Price at call : $41.96 — upside +48%
Today : $71.81 — upside -14%
Expected +48% · Actual +82% · Reason (≥ +15%) : ✓ Yes
🎯 on PTCT : 67% (12 calls matureds) · 📊 on Health : 49.3% · +6.9% (146 calls)
+82.2%
stock +82% · XLV +6%
matured Nov 19, 25
▲ Overweight · 🎯$64
Price at call : $36.75 — upside +74%
Today : $71.81 — upside -11%
Expected +74% · Actual +66% · Reason (≥ +15%) : ✓ Yes
🎯 on PTCT : 100% (12 calls matureds) · 📊 on Health : 50.6% · +13.8% (166 calls)
+65.6%
stock +66% · XLV -12%
matured Sep 20, 25
▲ Overweight · 🎯$64
Price at call : $35.48 — upside +80%
Today : $71.81 — upside -11%
Expected +80% · Actual +77% · Reason (≥ +15%) : ✓ Yes
🎯 on PTCT : 100% (12 calls matureds) · 📊 on Health : 50.6% · +13.8% (166 calls)
+77.2%
stock +77% · XLV -12%
matured Sep 17, 25
▲ Overweight · 🎯$64
Price at call : $33.93 — upside +89%
Today : $71.81 — upside -11%
Expected +89% · Actual +44% · Reason (≥ +15%) : ✓ Yes
🎯 on PTCT : 100% (12 calls matureds) · 📊 on Health : 50.6% · +13.8% (166 calls)
+44.2%
stock +44% · XLV -11%
matured Aug 21, 25
▲ Overweight · 🎯$64
Price at call : $31.31 — upside +104%
Today : $71.81 — upside -11%
Expected +104% · Actual +38% · Reason (≥ +15%) : ✓ Yes
🎯 on PTCT : 100% (12 calls matureds) · 📊 on Health : 50.6% · +13.8% (166 calls)
+38.3%
stock +38% · XLV -13%
matured Aug 9, 25
▲ Overweight · 🎯$62
Price at call : $34.17 — upside +81%
Today : $71.81 — upside -14%
Expected +81% · Actual +41% · Reason (≥ +15%) : ✓ Yes
🎯 on PTCT : 100% (12 calls matureds) · 📊 on Health : 50.6% · +13.8% (166 calls)
+40.9%
stock +41% · XLV -10%
matured Jul 16, 25
▲ Overweight · 🎯$62
Price at call : $31.17 — upside +99%
Today : $71.81 — upside -14%
Expected +99% · Actual +56% · Reason (≥ +15%) : ✓ Yes
🎯 on PTCT : 100% (12 calls matureds) · 📊 on Health : 50.6% · +13.8% (166 calls)
+55.9%
stock +56% · XLV -6%
matured Jul 1, 25
▼ Underperform · 🎯$32
Price at call : $36.52 — upside -12%
Today : $71.81 — upside -55%
Expected -12% · Actual +36% · Reason (≤ −15%) : ✗ No
🎯 on PTCT : 58% (12 calls matureds) · 📊 on Health : 51.3% · +3.0% (152 calls)
-35.8%
stock +36% · XLV -10%
matured Jun 21, 25
JP Morgan 
Jun 20, 24
▲ Overweight · 🎯$53
Price at call : $36.52 — upside +45%
Today : $71.81 — upside -26%
Expected +45% · Actual +36% · Reason (≥ +15%) : ✓ Yes
🎯 on PTCT : 67% (12 calls matureds) · 📊 on Health : 49.3% · +6.9% (146 calls)
+35.8%
stock +36% · XLV -10%
matured Jun 20, 25
Citigroup 
May 21, 24
▼ Sell · 🎯$26
Price at call : $38.64 — upside -33%
Today : $71.81 — upside -64%
Expected -33% · Actual +18% · Reason (≤ −15%) : ✗ No
🎯 on PTCT : 25% (12 calls matureds) · 📊 on Health : 43.8% · -5.4% (105 calls)
-17.8%
stock +18% · XLV -11%
matured May 21, 25
JP Morgan 
May 21, 24
▲ Overweight · 🎯$53
Price at call : $38.64 — upside +37%
Today : $71.81 — upside -26%
Expected +37% · Actual +18% · Reason (≥ +15%) : ✓ Yes
🎯 on PTCT : 67% (12 calls matureds) · 📊 on Health : 49.3% · +6.9% (146 calls)
+17.8%
stock +18% · XLV -11%
matured May 21, 25
▲ Overweight · 🎯$45
Price at call : $25.68 — upside +75%
Today : $71.81 — upside -37%
Expected +75% · Actual +76% · Reason (≥ +15%) : ✓ Yes
🎯 on PTCT : 100% (12 calls matureds) · 📊 on Health : 50.6% · +13.8% (166 calls)
+75.5%
stock +76% · XLV -0%
matured Apr 12, 25
▲ Overweight · 🎯$45
Price at call : $30.98 — upside +45%
Today : $71.81 — upside -37%
Expected +45% · Actual +71% · Reason (≥ +15%) : ✓ Yes
🎯 on PTCT : 100% (12 calls matureds) · 📊 on Health : 50.6% · +13.8% (166 calls)
+70.7%
stock +71% · XLV +2%
matured Mar 1, 25
Citigroup 
Oct 27, 23
▼ Sell · 🎯$17
Price at call : $18.51 — upside -8%
Today : $71.81 — upside -76%
Expected -8% · Actual +119% · Reason (≤ −15%) : ✗ No
🎯 on PTCT : 25% (12 calls matureds) · 📊 on Health : 43.8% · -5.4% (105 calls)
-118.7%
stock +119% · XLV +21%
matured Oct 26, 24
▼ Underperform · 🎯$23
Price at call : $25.68 — upside -10%
Today : $71.81 — upside -68%
Expected -10% · Actual +38% · Reason (≤ −15%) : ✗ No
🎯 on PTCT : 58% (12 calls matureds) · 📊 on Health : 51.3% · +3.0% (152 calls)
-38.2%
stock +38% · XLV +18%
matured Sep 18, 24
▼ Underperform · 🎯$42
Price at call : $43.46 — upside -3%
Today : $71.81 — upside -42%
Expected -3% · Actual -14% · Reason (≤ −15%) : ✗ No
🎯 on PTCT : 58% (12 calls matureds) · 📊 on Health : 51.3% · +3.0% (152 calls)
+14.4%
stock -14% · XLV +13%
matured May 23, 24
Citigroup 
May 24, 23
▲ Buy · 🎯$63
Price at call : $46.95 — upside +34%
Today : $71.81 — upside -12%
Expected +34% · Actual -21% · Reason (≥ +15%) : ✗ No
🎯 on PTCT : 25% (12 calls matureds) · 📊 on Health : 43.8% · -5.4% (105 calls)
-20.9%
stock -21% · XLV +12%
matured May 23, 24
▼ Underperform · 🎯$43
Price at call : $58.13 — upside -26%
Today : $71.81 — upside -40%
Expected -26% · Actual -43% · Reason (≤ −15%) : ✓ Yes
🎯 on PTCT : 58% (12 calls matureds) · 📊 on Health : 51.3% · +3.0% (152 calls)
+43.1%
stock -43% · XLV +12%
matured May 17, 24
Citigroup 
May 18, 23
▲ Buy · 🎯$70
Price at call : $58.13 — upside +20%
Today : $71.81 — upside -3%
Expected +20% · Actual -43% · Reason (≥ +15%) : ✗ No
🎯 on PTCT : 25% (12 calls matureds) · 📊 on Health : 43.8% · -5.4% (105 calls)
-43.1%
stock -43% · XLV +12%
matured May 17, 24
JP Morgan 
May 8, 23
▲ Overweight · 🎯$64
Price at call : $55.55 — upside +15%
Today : $71.81 — upside -11%
Expected +15% · Actual -43% · Reason (≥ +15%) : ✗ No
🎯 on PTCT : 67% (12 calls matureds) · 📊 on Health : 49.3% · +6.9% (146 calls)
-42.8%
stock -43% · XLV +7%
matured May 7, 24
Citigroup 
Apr 28, 23
▲ Buy · 🎯$67
Price at call : $55.14 — upside +22%
Today : $71.81 — upside -7%
Expected +22% · Actual -42% · Reason (≥ +15%) : ✗ No
🎯 on PTCT : 25% (12 calls matureds) · 📊 on Health : 43.8% · -5.4% (105 calls)
-41.7%
stock -42% · XLV +5%
matured Apr 27, 24
▼ Underperform · 🎯$36
Price at call : $43.52 — upside -17%
Today : $71.81 — upside -50%
Expected -17% · Actual -38% · Reason (≤ −15%) : ✓ Yes
🎯 on PTCT : 58% (12 calls matureds) · 📊 on Health : 51.3% · +3.0% (152 calls)
+37.8%
stock -38% · XLV +14%
matured Feb 22, 24
Citigroup 
Sep 1, 22
▲ Buy · 🎯$70
Price at call : $51.77 — upside +35%
Today : $71.81 — upside -3%
Expected +35% · Actual -23% · Reason (≥ +15%) : ✗ No
🎯 on PTCT : 25% (12 calls matureds) · 📊 on Health : 43.8% · -5.4% (105 calls)
-22.6%
stock -23% · XLV +5%
matured Sep 1, 23
▼ Underperform · 🎯$33
Price at call : $42.76 — upside -23%
Today : $71.81 — upside -54%
Expected -23% · Actual +26% · Reason (≤ −15%) : ✗ No
🎯 on PTCT : 58% (12 calls matureds) · 📊 on Health : 51.3% · +3.0% (152 calls)
-25.8%
stock +26% · XLV -5%
matured Apr 19, 23
JP Morgan 
Feb 23, 22
▲ Overweight · 🎯$76
Price at call : $35.63 — upside +113%
Today : $71.81 — upside +6%
Expected +113% · Actual +22% · Reason (≥ +15%) : ✓ Yes
🎯 on PTCT : 67% (12 calls matureds) · 📊 on Health : 49.3% · +6.9% (146 calls)
+22.1%
stock +22% · XLV +3%
matured Feb 23, 23
▼ Underperform · 🎯$38
Price at call : $37.37 — upside +2%
Today : $71.81 — upside -47%
Expected +2% · Actual +31% · Reason (≤ −15%) : ✗ No
🎯 on PTCT : 58% (12 calls matureds) · 📊 on Health : 51.3% · +3.0% (152 calls)
-30.5%
stock +31% · XLV -0%
matured Oct 18, 22
Citigroup 
Jan 5, 21
▲ Buy · 🎯$85
Price at call : $66.49 — upside +28%
Today : $71.81 — upside +18%
Expected +28% · Actual -41% · Reason (≥ +15%) : ✗ No
🎯 on PTCT : 25% (12 calls matureds) · 📊 on Health : 43.8% · -5.4% (105 calls)
-41.5%
stock -41% · XLV +17%
matured Jan 5, 22
JP Morgan 
Oct 7, 20
▲ Overweight
Actual -31% · Reason (≥ +15%) : ✗ No
🎯 on PTCT : 67% (12 calls matureds) · 📊 on Health : 49.3% · +6.9% (146 calls)
-31.4%
stock -31% · XLV +19%
matured Oct 7, 21
▲ Buy · 🎯$58
Price at call : $48.03 — upside +21%
Today : $71.81 — upside -19%
Expected +21% · Actual -17% · Reason (≥ +15%) : ✗ No
🎯 on PTCT : 58% (12 calls matureds) · 📊 on Health : 51.3% · +3.0% (152 calls)
-16.6%
stock -17% · XLV +26%
matured Aug 10, 21
Citigroup 
Apr 9, 20
▲ Buy
Actual +5% · Reason (≥ +15%) : ✗ No
🎯 on PTCT : 25% (12 calls matureds) · 📊 on Health : 43.8% · -5.4% (105 calls)
+4.8%
stock +5% · XLV +24%
matured Apr 9, 21
Citigroup 
Oct 30, 19
▲ Buy · 🎯$55
Price at call : $40.74 — upside +35%
Today : $71.81 — upside -23%
Expected +35% · Actual +32% · Reason (≥ +15%) : ✓ Yes
🎯 on PTCT : 25% (12 calls matureds) · 📊 on Health : 43.8% · -5.4% (105 calls)
+32.3%
stock +32% · XLV +7%
matured Oct 29, 20
▲ Buy · 🎯$49
Price at call : $40.04 — upside +22%
Today : $71.81 — upside -32%
Expected +22% · Actual +18% · Reason (≥ +15%) : ✓ Yes
🎯 on PTCT : 58% (12 calls matureds) · 📊 on Health : 51.3% · +3.0% (152 calls)
+18.3%
stock +18% · XLV +14%
matured May 12, 20
Bernstein 
Apr 11, 19
▲ Outperform · 🎯$48
Price at call : $38.6 — upside +24%
Today : $71.81 — upside -33%
Expected +24% · Actual +16% · Reason (≥ +15%) : ✓ Yes
🎯 on PTCT : 100% (1 call matured) · 📊 on Health : 25% · -33.8% (4 calls)
+16.4%
stock +16% · XLV +4%
matured Apr 10, 20
Citigroup 
Jul 24, 18
▲ Buy · 🎯$50
Price at call : $39.64 — upside +26%
Today : $71.81 — upside -30%
Expected +26% · Actual +15% · Reason (≥ +15%) : ✗ No
🎯 on PTCT : 25% (12 calls matureds) · 📊 on Health : 43.8% · -5.4% (105 calls)
+14.8%
stock +15% · XLV +5%
matured Jul 24, 19
JP Morgan 
Oct 9, 17
▼ Underweight
Actual +116% · Reason (≤ −15%) : ✗ No
🎯 on PTCT : 67% (12 calls matureds) · 📊 on Health : 49.3% · +6.9% (146 calls)
-115.7%
stock +116% · XLV +15%
matured Oct 9, 18
JP Morgan 
Jul 15, 15
▲ Overweight
Actual -88% · Reason (≥ +15%) : ✗ No
🎯 on PTCT : 67% (12 calls matureds) · 📊 on Health : 49.3% · +6.9% (146 calls)
-87.7%
stock -88% · XLV -3%
matured Jul 14, 16

Frequently asked questions

Should I buy PTC Therapeutics, Inc. stock?

This isn't buy advice. For PTC Therapeutics, Inc., the analyst consensus is "Buy", with an average price target of $104 (+45% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (6 calls tracked on PTC Therapeutics, Inc.). We show the numbers — you decide.

Is it too late to buy PTC Therapeutics, Inc.? How high can it go?

The most bullish analyst target on PTC Therapeutics, Inc. is $130 (+81% above today's price); the average is $104. That's the upside they see. Check how reliable those analysts have actually been on PTC Therapeutics, Inc. on our site before trusting it.

Is PTC Therapeutics, Inc. still a good buy?

The most useful "opinion" isn't an opinion — it's a track record: 19 analysts have a real record on PTC Therapeutics, Inc., the best hitting 100% over 6 calls. Current consensus: "Buy". Make your call on data, not noise.

Should you invest in PTC Therapeutics, Inc.? The case for and against

The arguments for and against, one by one, from the numbers: why invest in PTCT (and why hesitate).

What has PTC Therapeutics, Inc.'s past performance been?

Historical returns and a "how much if I had invested" calculator: PTCT performance & returns.

What is the best month to buy PTCT?

The 12 months ranked by the stock's past returns: best & worst month to buy PTCT.

Other Health stocks

Go further

JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)